China has reportedly begun human testing for a COVID-19 vaccine which utilizes nasal spray instead of an injection.

A report in Bloomberg cites a registration in the Chinese Clinical Trial Registry confirming that the nasal spray vaccine candidate developed by Xiamen University, Hong Kong University and Beijing Wantai Biological Pharmacy Enterprise is undergoing Phase I human testing.

Get the full story at our sister site, MassDevice.